LSV Asset Management Has $291.02 Million Holdings in Amdocs Limited (NASDAQ:DOX)

LSV Asset Management grew its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 11.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,180,501 shares of the technology company’s stock after purchasing an additional 317,412 shares during the quarter. LSV Asset Management owned about 2.82% of Amdocs worth $291,016,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in DOX. Alyeska Investment Group L.P. increased its position in Amdocs by 86.8% during the fourth quarter. Alyeska Investment Group L.P. now owns 1,681,074 shares of the technology company’s stock worth $143,127,000 after acquiring an additional 781,061 shares during the period. Vanguard Group Inc. grew its holdings in Amdocs by 16.1% during the 4th quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company’s stock worth $261,756,000 after acquiring an additional 426,035 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in Amdocs by 2,489.0% in the 4th quarter. The Manufacturers Life Insurance Company now owns 376,383 shares of the technology company’s stock valued at $32,045,000 after buying an additional 361,845 shares during the last quarter. Russell Investments Group Ltd. raised its holdings in Amdocs by 32.8% during the 4th quarter. Russell Investments Group Ltd. now owns 979,861 shares of the technology company’s stock worth $83,426,000 after purchasing an additional 242,093 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Amdocs by 69.2% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 459,830 shares of the technology company’s stock valued at $39,150,000 after acquiring an additional 188,129 shares during the last quarter. 92.02% of the stock is owned by institutional investors.

Amdocs Trading Down 1.0%

DOX stock opened at $84.49 on Friday. The company has a fifty day moving average price of $90.67 and a two-hundred day moving average price of $88.65. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.16 and a quick ratio of 1.16. The stock has a market cap of $9.54 billion, a price-to-earnings ratio of 17.79, a price-to-earnings-growth ratio of 1.41 and a beta of 0.52. Amdocs Limited has a one year low of $78.61 and a one year high of $95.41.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Wednesday, May 7th. The technology company reported $1.78 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.07. The firm had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.12 billion. Amdocs had a return on equity of 19.52% and a net margin of 11.39%. The company’s revenue for the quarter was down 9.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.56 EPS. Equities analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, July 25th. Stockholders of record on Monday, June 30th were issued a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, June 30th. Amdocs’s dividend payout ratio is 44.21%.

Wall Street Analyst Weigh In

Several research firms have weighed in on DOX. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a report on Saturday. Wolfe Research began coverage on Amdocs in a research report on Tuesday, July 8th. They issued an “outperform” rating on the stock. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Amdocs currently has a consensus rating of “Moderate Buy” and an average target price of $105.33.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.